Mugaba S - Search Results

1

Profile of T cell recognition of HIV type 1 consensus group M Gag and Nef peptides in a clade A1- and D-infected Ugandan population.

Serwanga J, Mugaba S, Pimego E, Nanteza B, Lyagoba F, Nakubulwa S, Heath L, Nsubuga RN, Ndembi N, Gotch F, Kaleebu P. Serwanga J, et al. Among authors: mugaba s. AIDS Res Hum Retroviruses. 2012 Apr;28(4):384-92. doi: 10.1089/AID.2011.0175. Epub 2011 Oct 17. AIDS Res Hum Retroviruses. 2012. PMID: 21867408 Free PMC article.

2

CD8 T-Cell Responses before and after Structured Treatment Interruption in Ugandan Adults Who Initiated ART with CD4 T Cells <200 Cell/μL: The DART Trial STI Substudy.

Serwanga J, Mugaba S, Betty A, Pimego E, Walker S, Munderi P, Gilks C, Gotch F, Grosskurth H, Kaleebu P. Serwanga J, et al. Among authors: mugaba s. AIDS Res Treat. 2011;2011:875028. doi: 10.1155/2011/875028. Epub 2011 Jan 18. AIDS Res Treat. 2011. PMID: 21490785 Free PMC article.

3

Coreceptor and cytokine concentrations may not explain differences in disease progression observed in HIV-1 clade A and D infected Ugandans.

Wright E, Mugaba S, Grant P, Parkes-Ratanshi R, Van der Paal L, Grosskurth H, Kaleebu P. Wright E, et al. Among authors: mugaba s. PLoS One. 2011;6(5):e19902. doi: 10.1371/journal.pone.0019902. Epub 2011 May 31. PLoS One. 2011. PMID: 21655330 Free PMC article.

4

Group M consensus Gag and Nef peptides are as efficient at detecting clade A1 and D cross-subtype T-cell functions as subtype-specific consensus peptides.

Mugaba S, Nakiboneka R, Nanyonjo M, Bugembe-Lule D, Kaddu I, Nanteza B, Tweyongyere R, Kaleebu P, Serwanga J. Mugaba S, et al. Vaccine. 2014 Jun 24;32(30):3787-95. doi: 10.1016/j.vaccine.2014.05.021. Epub 2014 May 14. Vaccine. 2014. PMID: 24837770 Free PMC article.

5

Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.

Serwanga J, Nakiboneka R, Mugaba S, Magambo B, Ndembi N, Gotch F, Kaleebu P. Serwanga J, et al. Among authors: mugaba s. Vaccine. 2015 Mar 30;33(14):1664-72. doi: 10.1016/j.vaccine.2015.02.037. Epub 2015 Feb 26. Vaccine. 2015. PMID: 25728323 Free PMC article.

6

Interferon gamma (IFN-γ) negative CD4+ and CD8+ T-cells can produce immune mediators in response to viral antigens.

Nakiboneka R, Mugaba S, Auma BO, Kintu C, Lindan C, Nanteza MB, Kaleebu P, Serwanga J. Nakiboneka R, et al. Among authors: mugaba s. Vaccine. 2019 Jan 3;37(1):113-122. doi: 10.1016/j.vaccine.2018.11.024. Epub 2018 Nov 17. Vaccine. 2019. PMID: 30459072 Free PMC article.

7

Mobilization of systemic CCL4 following HIV pre-exposure prophylaxis in young men in Africa.

Petkov S, Herrera C, Else L, Mugaba S, Namubiru P, Odoch G, Opoka D, Pillay AAP, Seiphetlo TB, Serwanga J, Ssemata AS, Kaleebu P, Webb EL, Khoo S, Lebina L, Gray CM, Martinson N, Fox J, Chiodi F. Petkov S, et al. Among authors: mugaba s. Front Immunol. 2022 Jul 27;13:965214. doi: 10.3389/fimmu.2022.965214. eCollection 2022. Front Immunol. 2022. PMID: 35967369 Free PMC article.

8

Examining oral pre-exposure prophylaxis (PrEP) literacy among participants in an HIV vaccine trial preparedness cohort study.

Chimukuche RS, Kawuma R, Mahapa N, Mkhwanazi S, Singh N, Siva S, Ruzagira E, Seeley J; PrEPVacc Study Group. Chimukuche RS, et al. BMC Health Serv Res. 2022 Nov 10;22(1):1336. doi: 10.1186/s12913-022-08730-8. BMC Health Serv Res. 2022. PMID: 36357877 Free PMC article.

9

Short-term oral pre-exposure prophylaxis against HIV-1 modulates the transcriptome of foreskin tissue in young men in Africa.

Petkov S, Herrera C, Else L, Lebina L, Opoka D, Seiphetlo TB, Pillay AA, Mugaba S, Namubiru P, Odoch G, Ssemata AS, Serwanga J, Kaleebu P, Webb EL, Khoo S, Martinson N, Gray CM, Fox J, Chiodi F. Petkov S, et al. Among authors: mugaba s. Front Immunol. 2022 Nov 18;13:1009978. doi: 10.3389/fimmu.2022.1009978. eCollection 2022. Front Immunol. 2022. PMID: 36479111 Free PMC article. Clinical Trial.

10

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.

Fernandez N, Hayes P, Makinde J, Hare J, King D, Xu R, Rehawi O, Mezzell AT, Kato L, Mugaba S, Serwanga J, Chemweno J, Nduati E, Price MA, Osier F, Ochsenbauer C, Yue L, Hunter E, Gilmour J; IAVI protocol C investigators. Fernandez N, et al. Among authors: mugaba s. Front Immunol. 2022 Dec 1;13:1029029. doi: 10.3389/fimmu.2022.1029029. eCollection 2022. Front Immunol. 2022. PMID: 36532063 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters